SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 8/02/16 Biolase, Inc 8-K:1,7,9 8/01/16 5:359K RR Donnelley/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 25K 2: EX-99.1 Miscellaneous Exhibit HTML 213K 3: EX-99.2 Miscellaneous Exhibit HTML 8K 4: EX-99.3 Miscellaneous Exhibit HTML 11K 5: EX-99.4 Miscellaneous Exhibit HTML 13K
EX-99.3 |
Exhibit 99.3
[BIOLASE, INC. LETTERHEAD]
Oracle Partners, L.P.
Oracle Institutional Partners, L.P.
Oracle Ten Fund Master, L.P.
Oracle Associates, LLC
Oracle Investment Management, Inc.
200 Greenwich Avenue, 3rd Floor
Re: | Amendment to Standstill Agreement |
Ladies and Gentlemen:
Reference is made to that certain Standstill Agreement, dated November 10, 2015 (the “Standstill Agreement”), among Biolase, Inc. (“Biolase”), Mr. Larry N. Feinberg, Oracle Partners, L.P., Oracle Institutional Partners, L.P., Oracle Ten Fund Master, L.P., Oracle Associates, LLC and Oracle Investment Management, Inc.
In consideration for the willingness of Oracle Partners L.P. and Oracle Institutional Partners L.P. to provide capital to Biolase on the terms and conditions set forth in the securities purchase agreement, dated August 1, 2016 (the “Securities Purchase Agreement”), that Biolase expects to enter into immediately following the execution hereof, and subject to the closing of the transactions contemplated thereby in accordance with the terms thereof, Biolase hereby agrees to amend the Standstill Agreement such that the reference to “25%” therein is changed to “30%,” effective immediately prior to the closing of the transactions contemplated by the Securities Purchase Agreement. Except as described in the immediately preceding sentence, the Standstill Agreement shall remain in full force and effect.
This letter agreement shall be governed by, and construed in accordance with, the internal laws of the State of Delaware without giving any effect to principles of conflicts of laws.
[Signatures follow]
Sincerely, | ||
BIOLASE, INC. | ||
By: | ||
Name: | Harold C. Flynn, Jr. | |
Title: | President and Chief Executive Officer |
The foregoing is hereby accepted:
LARRY N. FEINBERG | ||||||
ORACLE PARTNERS, L.P. | ||||||
By: ORACLE ASSOCIATES, LLC, its general partner | ||||||
By: | ||||||
Larry N. Feinberg, Managing Member | ||||||
ORACLE INSTITUTIONAL PARTNERS, L.P. | ||||||
By: ORACLE ASSOCIATES, LLC, its general partner | ||||||
By: | ||||||
Larry N. Feinberg, Managing Member | ||||||
ORACLE TEN FUND MASTER, L.P. | ||||||
By: ORACLE ASSOCIATES, LLC, its general partner | ||||||
By: | ||||||
Larry N. Feinberg, Managing Member | ||||||
ORACLE ASSOCIATES, LLC | ||||||
By: | ||||||
Larry N. Feinberg, Managing Member | ||||||
ORACLE INVESTMENT MANAGEMENT, INC. | ||||||
By: | ||||||
Larry N. Feinberg, Managing Member |
[Amendment to Standstill Agreement]
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 8/2/16 | |||
For Period End: | 8/1/16 | 10-Q, 8-K | ||
11/10/15 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/10/21 Biolase, Inc. 10-Q 9/30/21 84:13M Donnelley … Solutions/FA 8/13/21 Biolase, Inc. 10-Q 6/30/21 80:12M Donnelley … Solutions/FA 5/13/21 Biolase, Inc. 10-Q 3/31/21 81:9.4M Donnelley … Solutions/FA 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA 11/13/20 Biolase, Inc. 10-Q 9/30/20 81:11M ActiveDisclosure/FA 8/14/20 Biolase, Inc. 10-Q 6/30/20 89:12M ActiveDisclosure/FA |